Bitcoin investment company Parataxis Holdings has reached a 25 billion won investment agreement to go public
ChainCatcher news, according to PR Newswire, Bitcoin investment firm Parataxis Holdings LLC announced that it has reached a final investment agreement of 25 billion Korean won with Bridge Biotherapeutics, Inc.
The deal gives it control of the latter, and after the transaction is completed, Bridge Biotherapeutics will be renamed Parataxis Korea and continue to be listed on the KOSDAQ market in South Korea. The company is expected to announce more details about the transaction after holding a shareholders' meeting in August.
Related tags
ChainCatcher reminds readers to view blockchain rationally, enhance risk awareness, and be cautious of various virtual token issuances and speculations. All content on this site is solely market information or related party opinions, and does not constitute any form of investment advice. If you find sensitive information in the content, please click "Report", and we will handle it promptly.
Related tags